Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone, yet another busy day is on the way. And unfortunately, this appears to be a rather rainy one. Nonetheless, our spirits remain sunny. As you may recall, in times like these, we repeat a favorite saying courtesy of the Morning Mayor: 'Every brand new day should be unwrapped like a precious gift.' So while you tug on the ribbon, please join us for a welcome cup of stimulation and a few tidbits to get things going. Hope you accomplish much today and do stay in touch if you hear anything fascinating... FDA Places Partial Hold On Ariad Cancer Drug Trial Over Side Effects (Reuters) NIH Enrolls A Dozen Critically Ill Patients In Trials Despite Shutdown (Associated Press) Gilead Sciences Stop Leukemia Trial Early On Patient Benefit (Bloomberg News) Vivus Says Its Diet Pill Delayed Progression To Diabetes In Study (Associated Press) Congressman Supports Testing Diabetes Drug From Cuba (The Miami Herald) Using Byetta Or Bydureon With Avandia May Lower Heart Risk (MedPage Today) Takeda Ends Licensing Pact For Compound With Immunomedics (Pharma Times) EDITOR'S NOTE: Please check this post for additional stories during the day rain pic thx to...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs